Study Stopped
Inadequate recruitment
Self-discontinuation of Urinary Catheters in a Rural Population
1 other identifier
interventional
N/A
1 country
2
Brief Summary
The goal of this study is to understand patient satisfaction with two different ways of managing difficulty urinating after gynecologic surgery with a focus on those patients who receive care in a rural area. One common practice is to have an "office catheter removal." This means, if a patient has trouble urinating after surgery and goes home with a foley catheter, they usually have to come back to the clinic within 2-3 days to have the catheter removed and to do a test to see if they can urinate on their own. For some patients, coming back to the clinic so soon after surgery can be difficult, especially for those patients who live far away or are dependent on others for getting to appointments. A second, less common, practice is to have patients remove their own catheter at home, or "self-removal of urinary (Foley) catheter." With self-removal, patients remove their Foley catheter at home, and confirm that they are urinating normally. This approach has been shown to be safe, with similar patient satisfactions, and success, but those studies did not take into account situations where patients may live a rural area and/or travel a long distance to the medical center to receive care. This study is comparing the in-office removal with self-removal. The goal is to find out which option patients prefer, how convenient each approach is, and how well they work. The main goal of this study is to understand patient satisfaction and improve care after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedStudy Start
First participant enrolled
August 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 1, 2026
August 1, 2025
2 months
June 18, 2025
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Satisfaction with Void Trial Process
Measured using a 0-100 mm visual analog scale (VAS) administered at the 2-week follow-up visit.
2 weeks postoperatively
Secondary Outcomes (4)
Postoperative Urinary Retention
within 72 hours postoperatively
Urinary tract infection
Within 30 days postoperatively
Adverse Events Related to Foley Catheter Removal or Void Trial
up to 30 days postoperatively
Healthcare Resource Utilization
up to 30 days postoperatively
Study Arms (2)
At-home passive void trial
EXPERIMENTALParticipants will be instructed to remove their foley catheter at home 48-72 hours postoperatively. After removal, they will perform a passive void trial and will be monitored for successful voiding within a designated time frame. Instructions will be provided, and participants will be advised to contact the clinic if unable to void.
In-office backfill void trial
ACTIVE COMPARATORParticipants will return to the clinic 48-72 hours postoperatively for standard foley catheter removal and a backfill void trial. The bladder will be filled with 300 mL of sterile water, and voiding will be assessed in clinic per institutional protocol.
Interventions
Participants will return to clinic for removal of their foley catheter and undergo a backfill void trial. Standard protocols for instillation and assessment of urinary retention will be followed.
Participants will remove their foley catheter at home and perform a passive void trial. They will be instructed to drink fluids and attempt to void within a designated time frame. Instructions and support will be provided to ensure safety and follow-up, including clinic contact if voiding is unsuccessful.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Undergoing gynecologic surgery with planned postoperative trial of void to confirm normal voiding prior to discharge home
- Willing and able to provide informed consent
- English-speaking
- Willing to comply with study procedures, including follow-up phone calls and surveys
You may not qualify if:
- Known urinary tract abnormalities (e.g., urethral strictures, neurogenic bladder) that may affect voiding.
- Diagnosis of voiding dysfunction prior to surgery with need to self-catheterize.
- Perioperative complication that necessitates indwelling catheter for a specific duration of time.
- Joint surgeries that would affect ability to comply with study methods (e.g. that necessitates longer inpatient admission or reduces mobility beyond that normal for postop patients after gynecologic surgery)
- Presence of significant cognitive or physical impairments that limit the ability to comply with study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03766, United States
Dartmouth Manchester Ambulatory Surgery Center
Manchester, New Hampshire, 03104, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Ekaterina Grebenyuk, MD
Dartmouth-Hitchcock Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 18, 2025
First Posted
June 27, 2025
Study Start
August 12, 2025
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
April 1, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
This is a single-center, investigator-initiated study. There are no plans to share individual participant data at this time.